Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway
Biomolecules · 2025
DOI: 10.3390/biom15091211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Liang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Tianjin First Central Hospital, College of Pharmacy, Nankai University, Tianjin 300353, China. Hauptthemen laut MEDLINE: Iridoid Glucosides, Bleomycin, Transforming Growth Factor beta1, Signal Transduction. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by the accumulation of fibrotic tissue in the lungs, leading to impaired gas exchange and respiratory failure, with a poor prognosis and limited treatment options. Oleuropein, a compound extracted from olive leaves, demonstrates a range of pharmacological activities, including benefits for non-alcoholic fatty liver disease and cardiac fibrosis. This study investigates the therapeutic potential of oleuropein for IPF and its underlying mechanisms. We first established a bleomycin-induced mouse model of pulmonary fibrosis and evaluated the in vivo efficacy of oleuropein. Our findings demonstrated that oleuropein significantly alleviated lung fibrosis and improved pulmonary function. Through in vitro experiments, we found that oleuropein inhibited TGF-β1-induced fibroblast migration, activation, autophagy, and apoptotic resistance, and mechanistically, oleuropein could regulate the TGF-β1/Smad and TGF-β1/mTOR signaling pathways in fibroblasts. Additionally, molecular docking analysis indicated that FAP-α is a potential target of oleuropein, displaying strong binding affinity. The effects of oleuropein on fibroblasts were markedly disrupted in FAP-α knockout cells. In conclusion, oleuropein exerts its beneficial effects by targeting FAP-α and inhibiting TGF-β1-related signaling pathways, improving the pathological characteristics of pulmonary fibrosis in mouse models, and demonstrating promising application prospects for the treatment of IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Tianjin First Central Hospital, College of Pharmacy, Nankai University, Tianjin 300353, China.
- Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin 300457, China.
ORCID-Profile: Yuming Liu, Honggang Zhou
Förderung
- The National Natural Science Foundation of China
Zitieren
APA
Zhang, L., Liu, Z., Hu, Y., Liu, X., Yang, Z., Liu, Y., Jiao, R., Gu, X., Zhang, W., Li, X., & Zhou, H. (2025). Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway. Biomolecules. https://doi.org/10.3390/biom15091211
Vancouver
Zhang L, Liu Z, Hu Y, Liu X, Yang Z, Liu Y, et al. Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway. Biomolecules. 2025. doi:10.3390/biom15091211
BibTeX
@article{Zhang2025,
author = {Zhang, Liang and Liu, Zhigang and Hu, Yayue and Liu, Xueze and Yang, Zhongyi and Liu, Yuming and Jiao, Ran and Gu, Xiaoting and Zhang, Weidong and Li, Xiaohe and Zhou, Honggang},
title = {Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15091211}
}
EUVIMED